Evidence map›Paper›PMID 32553489›Full record

ArticleJournal of the American Medical Directors Association2020

High Prevalence of Multidrug-Resistant Organism Colonization in 28 Nursing Homes: An "Iceberg Effect".

James A McKinnell, Loren G Miller, Raveena D Singh, Gabrielle Gussin, Ken Kleinman, Job Mendez, Bryn Laurner, Tabitha D Catuna, Lauren Heim, Raheeb Saavedra and 35 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Medical Directors Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
0.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Methicillin-resistant Staphylococcus aureus.Nature reviews. Disease primers · 2026
    Review
  4. Article
  5. A Public Health Approach to Antimicrobial Stewardship in Long-term Care Facilities: A Multifaceted Program in Massachusetts.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Risk factors for colonization with multidrug-resistant Gram-negative bacteria andFrontiers in cellular and infection microbiology · 2023
    Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

45 authors at 9 institutions in 1 country.

James A McKinnellDepartment of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA; Los Angeles County Department of Public Health, Healthcare Outreach Unit, Los Angeles, CA, USA; Expert Stewardship, Newport, CA, USA. Electronic address: Dr.McKinnell@gmail.com.
Loren G MillerDepartment of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
Raveena D SinghDivision of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
Gabrielle GussinDivision of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
Ken KleinmanUniversity of Massachusetts Amherst School of Public Health and Health Sciences, Amherst, MA, USA.
Job MendezDepartment of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
Bryn LaurnerDepartment of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
Tabitha D CatunaDivision of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
Lauren HeimDivision of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
Raheeb SaavedraDivision of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
James FelixDepartment of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
Crystal TorresDepartment of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
Justin ChangDivision of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
Marlene EstevezDivision of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
Joanna MendezDepartment of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
Gregory TchakalianDepartment of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
Leah BloomfieldDepartment of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
Sandra CejaDepartment of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
Ryan FrancoDepartment of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
Aaron MinerDepartment of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
Aura HurtadoDepartment of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
Ratharo HeanDepartment of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
Alex VarastehDepartment of Medicine, Infectious Disease Clinical Outcomes Research (ID-CORE), LA Biomed at Harbor-UCLA Medical Center, Torrance, CA, USA.
Philip A RobinsonExpert Stewardship, Newport, CA, USA; Hoag Hospital, Newport, CA, USA.
Steven ParkDepartment of Pathology and Laboratory Medicine, University of California, Irvine School of Medicine, Irvine, CA, USA.
Steven TamDivision of Geriatrics, Department of Medicine, University of California Irvine, Orange, CA, USA.
Thomas TjoaDivision of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
Jiayi HeDivision of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
Shalini AgrawalDivision of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
Stacey YamaguchiDivision of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
Harold CustodioDivision of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
Jenny NguyenDivision of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA.
Cassiana E BittencourtDepartment of Pathology and Laboratory Medicine, University of California, Irvine School of Medicine, Irvine, CA, USA.
Kaye D EvansDepartment of Pathology and Laboratory Medicine, University of California, Irvine School of Medicine, Irvine, CA, USA.
Vincent MorDepartment of Health Services, Policy and Practice, Brown University School of Public Health, Providence, RI, USA; Center of Innovation in Long-Term Services and Supports, Veterans Affairs Medical Center, Providence VA Medical Center, Providence, RI, USA; Center for Long-Term Care Quality and Innovation, Brown University School of Public Health, Providence, RI, USA.
Kevin McConeghyDepartment of Health Services, Policy and Practice, Brown University School of Public Health, Providence, RI, USA; Center of Innovation in Long-Term Services and Supports, Veterans Affairs Medical Center, Providence VA Medical Center, Providence, RI, USA; Center for Long-Term Care Quality and Innovation, Brown University School of Public Health, Providence, RI, USA.
Robert A WeinsteinCook County Health and Hospitals System, Chicago, IL, USA; Department of Medicine, Rush University Medical Center, Chicago, IL, USA.
Mary K HaydenDepartment of Medicine, Rush University Medical Center, Chicago, IL, USA.
Nimalie D StoneDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Karl SteinbergCalifornia Association of Long Term Care Medicine, Santa Clarita, CA, USA.
Nancy BeechamThe National Association of Directors of Nursing Administration in Long Term Care, Springdale, OH, USA.
Jocelyn MontgomeryCalifornia Association of Health Facilities, Sacramento, CA, USA.
Walters DeAnnCalifornia Association of Health Facilities, Sacramento, CA, USA.
Ellena M PetersonDepartment of Pathology and Laboratory Medicine, University of California, Irvine School of Medicine, Irvine, CA, USA.
Susan S HuangDivision of Infectious Diseases, Department of Medicine, University of California Irvine School of Medicine, Irvine, CA, USA; Department of Medicine, Health Policy Research Institute, University of California Irvine School of Medicine, Irvine, CA, USA.
University of California, Irvine · USHarbor–UCLA Medical Center · USNia Association · USBrown University · USRush University Medical Center · USCenters for Disease Control and Prevention · USHoag Memorial Hospital Presbyterian · USLos Angeles County Department of Public Health · USUniversity of Massachusetts Amherst · US

Funding

PROTECT Trial: Protecting nursing home residents from infections and readmissionsR01HS024286 · AHRQ · UNIVERSITY OF CALIFORNIA-IRVINE · PI HUANG, SUSAN S. · 2015 to 2015
$2.3M
AHRQ HHS R01 HS024286
6 · The paper itself

Abstract

objectiveDetermine the prevalence of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus spp. (VRE), extended-spectrum beta-lactamase producing organisms (ESBLs), and carbapenem-resistant Enterobacteriaceae (CRE) among residents and in the environment of nursing homes (NHs).

designPoint prevalence sampling of residents and environmental sampling of high-touch objects in resident rooms and common areas.

settingTwenty-eight NHs in Southern California from 2016 to 2017.

participantsNH participants in Project PROTECT, a cluster-randomized trial of enhanced bathing and decolonization vs routine care.

methodsFifty residents were randomly sampled per NH. Twenty objects were sampled, including 5 common room objects plus 5 objects in each of 3 rooms (ambulatory, total care, and dementia care residents).

resultsA total of 2797 swabs were obtained from 1400 residents in 28 NHs. Median prevalence of multidrug-resistant organism (MDRO) carriage per NH was 50% (range: 24%-70%). Median prevalence of specific MDROs were as follows: MRSA, 36% (range: 20%-54%); ESBL, 16% (range: 2%-34%); VRE, 5% (range: 0%-30%); and CRE, 0% (range: 0%-8%). A median of 45% of residents (range: 24%-67%) harbored an MDRO without a known MDRO history. Environmental MDRO contamination was found in 74% of resident rooms and 93% of common areas. CONCLUSIONS AND IMPLICATIONS: In more than half of the NHs, more than 50% of residents were colonized with MDROs of clinical and public health significance, most commonly MRSA and ESBL. Additionally, the vast majority of resident rooms and common areas were MDRO contaminated. The unknown submerged portion of the iceberg of MDRO carriers in NHs may warrant changes to infection prevention and control practices, particularly high-fidelity adoption of universal strategies such as hand hygiene, environmental cleaning, and decolonization.

Indexed as

Cross InfectionMethicillin-Resistant Staphylococcus aureusVancomycin-Resistant EnterococciDrug Resistance, Multiple, BacterialHumansNursing HomesPrevalenceCREepidemiologyESBLinfection controlInfectious diseaseMDRO colonizationMRSA

Identifiers

PMID32553489
PMCPMC7708431
OpenAlexW3036055420

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.